Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Atlas Genetics Raises $35M in Series D Fundraising

Atlas Genetics Raises $35M in Series D Fundraising

Jan 23, 2017

NEW YORK (GenomeWeb) ­– Atlas Genetics announced today that it has completed a $35 million Series D financing round.

All of Atlas' Series C round investors — who contributed $20 million in January 2015 — participated in the Series D round. These include Novartis Venture Funds, Consort Medical, Johnson & Johnson Innovation - JJDC, Inc, Life Science Partners, BB Biotech Ventures, RMI Partners, and Technology Venture Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In PCR

  1. FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

  2. Mobidiag Receives CE Mark for Two PCR SARS-CoV-2 Tests

  3. Bio-Me Eyes PCR-Based Microbiome Profiling Technology for Future CDx

    Premium

  4. LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

  5. Progenity Files for IPO, Seeks to Raise up to $100M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.